Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_predicted type ECO_0000266 NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- source_evidence_predicted label "DisGeNET evidence - PREDICTED" NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- source_evidence_predicted comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations." NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_assertion description "[When beta-aminopropionitrile, a specific inhibitor of lysyl oxidase, was administered before the onset of DOCA-salt hypertension, the aortic collagen content was reduced markedly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_assertion evidence source_evidence_predicted NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_assertion SIO_000772 24127 NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_assertion wasDerivedFrom rgd-20150221 NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_assertion wasGeneratedBy ECO_0000218 NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.
- rgd-20150221 importedOn "2015-02-21" NP41351.RAgxFw-SwT1ngFImxIvvj6zmisjyRZFL2PpP-4TA1fwo4130_provenance.